Equity Overview
Price & Market Data
Price: $1.41
Daily Change: $0.00 / 0.00%
Daily Range: $1.16 - $1.48
Market Cap: $157,468,928
Daily Volume: 2,163,888
Performance Metrics
1 Week: 27.03%
1 Month: 38.24%
3 Months: 47.83%
6 Months: 31.78%
1 Year: 52.98%
YTD: 47.83%
Company Details
Employees: 22
Sector: Health technology
Industry: Biotechnology
Country: Canada
Details
Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the developing of anti-fibrotic and anti-inflammatory therapies for the treatment of heart diseases. Its lead product candidate is CardiolRx, which is in Phase III multi-national, randomized, double-blind, and placebo-controlled study to evaluate the efficacy and safety of CardiolRx in acute myocarditis, as well as for the treatment of recurrent pericarditis. The company is also developing CRD-38 injection for subcutaneous administration that is in preclinical development for the treatment of heart failure. It has a license agreement with Meros. The company was incorporated in 2017 and is headquartered in Oakville, Canada.